Porocarcinoma: Clinical and Histological Features, Immunohistochemistry and Outcomes: A Systematic Review.
Thomas BienstmanCanan GüvençMarjan GarmynPublished in: International journal of molecular sciences (2024)
Porocarcinoma (PC) is a rare adnexal tumor, mainly found in the elderly. The tumor arises from the acrosyringium of eccrine sweat glands. The risk of lymph node and distant metastasis is high. Differential diagnosis with squamous cell carcinoma is difficult, although NUT expression and YAP1 fusion products can be very useful for diagnosis. Currently, wide local excision is the main surgical treatment, although Mohs micrographic surgery is promising. To date, there is no consensus regarding the role of sentinel lymph node biopsy and consequential lymph node dissection. No guidelines exist for radiotherapy, which is mostly performed based on tumor characteristics and excision margins. Only a few studies report systemic treatment for advanced PC, although therapy with pembrolizumab and EGFR inhibitors show promise. In this review, we discuss epidemiology, clinical features, histopathological features, immunohistochemistry and fusion products, surgical management and survival outcomes according to stage, surgical management, radiotherapy and systemic therapy.
Keyphrases
- lymph node
- sentinel lymph node
- early stage
- squamous cell carcinoma
- neoadjuvant chemotherapy
- locally advanced
- small cell lung cancer
- minimally invasive
- radiation therapy
- poor prognosis
- tyrosine kinase
- rectal cancer
- risk factors
- type diabetes
- prostate cancer
- adipose tissue
- stem cells
- metabolic syndrome
- lymph node metastasis
- acute coronary syndrome
- basal cell carcinoma
- replacement therapy
- deep learning
- insulin resistance
- artificial intelligence
- atrial fibrillation
- ultrasound guided
- robot assisted
- drug induced
- big data